123 related articles for article (PubMed ID: 33309480)
1. Impaired secretion of platelet granules in patients with Duchenne muscular dystrophy - results of a prospective diagnostic study.
Schorling DC; Müller CK; Pechmann A; Borell S; Rosenfelder S; Kölbel H; Schara U; Zieger B; Kirschner J
Neuromuscul Disord; 2021 Jan; 31(1):35-43. PubMed ID: 33309480
[TBL] [Abstract][Full Text] [Related]
2. Impaired primary hemostasis with normal platelet function in Duchenne muscular dystrophy during highly-invasive spinal surgery.
Turturro F; Rocca B; Gumina S; De Cristofaro R; Mangiola F; Maggiano N; Evangelista A; Salsano V; Montanaro A
Neuromuscul Disord; 2005 Aug; 15(8):532-40. PubMed ID: 16009551
[TBL] [Abstract][Full Text] [Related]
3. Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery.
Labarque V; Freson K; Thys C; Wittevrongel C; Hoylaerts MF; De Vos R; Goemans N; Van Geet C
Hum Mol Genet; 2008 Feb; 17(3):357-66. PubMed ID: 17981813
[TBL] [Abstract][Full Text] [Related]
4. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.
Daoud F; Angeard N; Demerre B; Martie I; Benyaou R; Leturcq F; Cossée M; Deburgrave N; Saillour Y; Tuffery S; Urtizberea A; Toutain A; Echenne B; Frischman M; Mayer M; Desguerre I; Estournet B; Réveillère C; Penisson-Besnier ; Cuisset JM; Kaplan JC; Héron D; Rivier F; Chelly J
Hum Mol Genet; 2009 Oct; 18(20):3779-94. PubMed ID: 19602481
[TBL] [Abstract][Full Text] [Related]
6. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.
Yamamoto T; Awano H; Zhang Z; Sakuma M; Kitaaki S; Matsumoto M; Nagai M; Sato I; Imanishi T; Hayashi N; Matsuo M; Iijima K; Saegusa J
Circ Genom Precis Med; 2018 Jan; 11(1):e001782. PubMed ID: 29874176
[TBL] [Abstract][Full Text] [Related]
8. Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey.
Schorling DC; Müller CK; Pechmann A; Borell S; Langer T; Thiele S; Walter MC; Zieger B; Kirschner J
Acta Myol; 2020 Mar; 39(1):2-12. PubMed ID: 32607473
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
Kreis R; Wingeier K; Vermathen P; Giger E; Joncourt F; Zwygart K; Kaufmann F; Boesch C; Steinlin M
NMR Biomed; 2011 Apr; 24(3):253-62. PubMed ID: 21404337
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy.
Papa R; Madia F; Bartolomeo D; Trucco F; Pedemonte M; Traverso M; Broda P; Bruno C; Zara F; Minetti C; Fiorillo C
Pediatr Neurol; 2016 Feb; 55():58-63. PubMed ID: 26718981
[TBL] [Abstract][Full Text] [Related]
12. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
[TBL] [Abstract][Full Text] [Related]
14. DMD and West syndrome.
Cardas R; Iliescu C; Butoianu N; Seferian A; Gataullina S; Gargaun E; Nectoux J; Bienvenu T; Craiu D; Gidaro T; Servais L
Neuromuscul Disord; 2017 Oct; 27(10):911-913. PubMed ID: 28802771
[TBL] [Abstract][Full Text] [Related]
15. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China.
Wang DN; Wang ZQ; Yan L; He J; Lin MT; Chen WJ; Wang N
Neuromuscul Disord; 2017 Aug; 27(8):715-722. PubMed ID: 28318817
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.
Preethish-Kumar V; Shah A; Kumar M; Ingalhalikar M; Polavarapu K; Afsar M; Rajeswaran J; Vengalil S; Nashi S; Thomas PT; Sadasivan A; Warrier M; Nalini A; Saini J
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1271-1278. PubMed ID: 32616576
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
19. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
20. Combining genetics, neuropsychology and neuroimaging to improve understanding of brain involvement in Duchenne muscular dystrophy - a narrative review.
Doorenweerd N
Neuromuscul Disord; 2020 Jun; 30(6):437-442. PubMed ID: 32522501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
